ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3018

Paracrine Effect of Proteins Secreted By Normal Lung Microvascular Endothelial Cells Undergoing Endothelial Mesenchymal Transition on the Expression of Genes Associated with Tissue Fibrosis in Normal Human Lung Fibroblasts

Sonsoles Piera-Velazquez1, Kerri Fasino2 and Sergio A. Jimenez3, 1Jefferson Institute of Molecular Medicine, Thomas Jefferson Univ, Philadelphia, PA, 2Jefferson Institute of Molecular Medicine and Division of Connective Tissue Diseases, Thomas Jefferson University, Philadelphia, PA, 3Div Connective Tissue Diseases, Thomas Jefferson Univ, Philadelphia, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: endothelial cells, fibrosis and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Progressive tissue fibrosis and microvascular alterations are the hallmarks of Systemic Sclerosis (SSc). The mechanisms involved in SSc pathogenesis are complex and have not been fully elucidated. One notable feature of SSc is the extension of the pathologic process to normal tissues. The mechanisms involved in this topographic extension have remained elusive. Recent studies suggested that the phenotypic transition of endothelial cells (EC) into mesenchymal cells (endothelial to mesenchymal transition; EndoMT) may be involved in the progressive tissue fibrosis and fibroproliferative vasculopathy in SSc although the mechanisms involved have not been elucidated. We here suggest that one potential mechanism may be that EndoMT activated EC exert paracrine effects on normal/healthy fibroblasts and EC and induce them to express a profibrotic phenotype and transdifferentiate into activated profibrotic cells. The purpose of the study was to evaluate whether secreted molecules released by microvascular lung EC undergoing EndoMT exert paracrine effects on normal human pulmonary fibroblasts inducing them to become profibrotic.

Methods: Normal human lung fibroblasts and microvascular EC were isolated from normal lung tissues by enzymatic digestion with collagenase. The isolated cell suspension was incubated with CD45 microbeads to remove leukocytes. Fibroblasts and EC were isolated employing anti-human CD31 antibody magnetic beads. The CD31- fibroblasts and the CD31+ EC were expanded separately. For EndoMT induction the lung microvascular EC were treated with TGF-β1 or TGF-β2 for 48 h. Following a change of media to serum-free media for 24h the supernatants were collected and aliquotes added to triplicate wells of normal human lung fibroblasts. After 24h, culture supernatants were isolated for Western blot analysis. The cells were lysed and total fibroblast RNA isolated and cDNA generated. Expression of various fibrosis-associated +genes was assessed by quantitative real time PCR.  Validation of the gene expression results was performed employing Western blot analysis of secreted and intracellular proteins. 

Results: RTPCR results showed a marked increase in levels of COL1A2, COL3A1, FN1, CTGF and TGFβ1 mRNA in normal lung fibroblasts treated with supernatants from normal lung microvascular EC pretreated with TGF-β1 or TGF-β2 compared to medium from untreated EC. Increased amounts of fibronectin were found in the media of lung fibroblasts treated with supernatants from the lung microvascular EC treated with TGF-β1 or TGF-β2.

Conclusion: Treatment of normal lung fibroblasts with proteins released by cultured human lung microvascular EC induced to undergo EndoMT in vitro resulted in a profound change in the expression of numerous profibrotic genes. The results demonstrated potent paracrine effects of EndoMT-activated lung microvascular EC on normal target lung fibroblasts and suggest a novel mechanism for the progression of SSc-associated pulmonary fibrosis.


Disclosure: S. Piera-Velazquez, None; K. Fasino, None; S. A. Jimenez, None.

To cite this abstract in AMA style:

Piera-Velazquez S, Fasino K, Jimenez SA. Paracrine Effect of Proteins Secreted By Normal Lung Microvascular Endothelial Cells Undergoing Endothelial Mesenchymal Transition on the Expression of Genes Associated with Tissue Fibrosis in Normal Human Lung Fibroblasts [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/paracrine-effect-of-proteins-secreted-by-normal-lung-microvascular-endothelial-cells-undergoing-endothelial-mesenchymal-transition-on-the-expression-of-genes-associated-with-tissue-fibrosis-in-normal/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/paracrine-effect-of-proteins-secreted-by-normal-lung-microvascular-endothelial-cells-undergoing-endothelial-mesenchymal-transition-on-the-expression-of-genes-associated-with-tissue-fibrosis-in-normal/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology